1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride:Exports & Compliance White Paper 2026

I. Executive Summary

Regulated research substance — compliance notice. MPTP hydrochloride, CAS 23007-85-4, the hydrochloride salt of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, is a potent and selective dopaminergic neurotoxin. It is converted in vivo to the 1-methyl-4-phenylpyridinium species, which destroys dopaminergic neurones and produces an irreversible parkinsonian syndrome in exposed humans. It has no approved therapeutic indication of any kind. It is not a medicinal product, not a dietary or consumer article and not a veterinary product, and it must never be administered to humans. It contains no dosage information and no instructions for human or animal use.

The only legitimate commercial framing for this substance is that of a controlled research material supplied under restriction to qualified institutions. Every element of a transaction therefore turns on governance rather than on price: verification of the institution's licences, ethical approvals and containment capability; a signed end-use declaration; know-your-customer screening of the buyer, the laboratory and the responsible investigator; import and export verification against the laws of the origin, transit and destination countries; and chain of custody to final disposal.

Technically, the defensible product is an analytically certified reference material rather than a bulk chemical: a small, sealed, accurately valued quantity with a stated measurement uncertainty, full structural confirmation, a defined related-substance profile produced under ISO/IEC 17025 and ISO 17034. This paper sets out what that documentation should contain, how the hazard is controlled in manufacture and handling, and where the compliance boundaries lie.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The free base has the formula C12H15N and the hydrochloride salt a molecular weight near 210 g/mol. The salt is supplied as a solid and is handled exclusively as a sealed, contained material. Two properties govern every control decision: extreme potency by all exposure routes, and the metabolic conversion that turns the parent into the actual toxicant.

• Metabolic Activation and Selective Neurotoxicity: The parent tetrahydropyridine is oxidised by monoamine oxidase B to the corresponding pyridinium species, which is then taken up selectively by dopaminergic neurones through the dopamine transporter. Inside the neurone it inhibits mitochondrial complex I, collapsing cellular energy metabolism and producing selective degeneration of the nigrostriatal pathway. The practical consequence is severe: the effect is cumulative, irreversible and without antidote. Any occupational exposure scenario must therefore be built around prevention of any exposure at all, not around a tolerable intake.
• Physical Form, Stability and Storage Drivers: As a hydrochloride salt the material is a solid, which reduces but does not eliminate the inhalation hazard. It should be stored cold, dry and protected from light in sealed containers, because oxidation generates the pyridinium species, an impurity and an additional toxicant. Cold, dark, dry storage is thus both a quality measure and a safety measure, and the container should never be opened outside a validated containment device.

2.2 Manufacturing and Containment Posture

This section is deliberately framed as a control statement rather than as a manufacturing description, and the boundary is intentional.

• Disclosure Boundary — No Process Enablement: At the class level only, the substance belongs to the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine family, a chemotype described in the historical toxicological literature, and its preparation is not a subject this paper will address. We do not provide, and will not provide on request, synthetic procedures, reagent or precursor lists, scales, yields, apparatus specifications, purification protocols or sourcing guidance for this compound or for its immediate analogues. Institutions requiring material should obtain it from an established, licensed supplier and should not attempt its preparation.
• OEB 5 Containment, HBEL and Occupational Hygiene: A compound of this potency belongs in the highest occupational exposure band. That means a health-based exposure limit and permitted daily exposure set at a very low level by a qualified toxicologist, translated into a containment strategy of closed handling in isolators or glove boxes, dedicated or campaign-dedicated equipment, negative-pressure suites with high-efficiency particulate filtration, and no open handling of the solid outside containment. Supporting controls include written procedures, trained and medically surveilled personnel and validated decontamination kits.

2.3 Core Application Matrix

• Certified Analytical Reference Standard: The most defensible commercial use is as a reference material for analytical chemistry: identification and quantification of the substance and its oxidation products in forensic, toxicological and environmental matrices, calibration of liquid-chromatography tandem mass-spectrometry methods, and method development in laboratories accredited to ISO/IEC 17025. Critical attributes are value assignment with stated uncertainty, structural confirmation, a related-substance profile and full documentation.
• Restricted Neuroscience Research at Licensed Institutions: The substance is used, under strict institutional control, in research on dopaminergic neurodegeneration. Any such use must be conducted by a licensed establishment, under a protocol reviewed and approved by the responsible animal ethics committee and institutional safety committee, with defined containment, waste inactivation and trained personnel. No protocol detail, exposure regime or dose is provided or implied anywhere in this paper, and none should be requested.
• Compliance, Training and Method Development: Small quantities are also supplied for the development and validation of detection and decontamination methods, for occupational-hygiene surface-sampling studies in facilities that handle the compound, and for regulator-facing method work.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand is small, inelastic and entirely institutional. It arises from neuroscience research programmes into dopaminergic degeneration, from forensic and toxicological laboratories that must be able to identify the compound, and from occupational-hygiene method development in facilities that already handle it. The market behaves less like a chemical market than like a controlled-substance market: volumes are stable and qualification is dominated by documentation and audit.

3.2 Capacity Distribution and Export Flows

Legitimate supply is concentrated among a small number of established reference-material producers and specialist research-chemical suppliers in Europe, North America and Asia, each operating within its own national controlled-substance framework. Export flows are correspondingly narrow and heavily documented: shipments move on a per-order basis, frequently by secure courier rather than through general freight, with chain-of-custody records, import permissions where required and recipient verification before dispatch. Restrictive Class 6.1 packing rules and carrier refusals are themselves a constraint on distribution.

3.3 Market Bifurcation and Pricing Dynamics

The market divides between uncertified research-grade material and certified reference material, and the gap between them is mostly documentation. Certified material carries a value assignment with a stated expanded uncertainty, production and measurement under ISO/IEC 17025 and ISO 17034, homogeneity and stability data, and a full certificate; uncertified material does not. For a compound of this hazard, price is secondary: containment, disposal, surveillance and governance costs exceed the purchase price.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

Compliance, not chemistry, defines this product. The governing obligations fall into four groups: the institution's authorisation to hold and use the substance, the supplier's duty to qualify the buyer, the transport and inventory obligations attaching to the substance itself, and destruction of residues.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH Registration and CLP Acute-Toxicity Classification: Chemical-inventory obligations apply to the substance as manufactured or imported, and any supply at or above registration thresholds requires a dossier with the full hazard dataset and stringent risk-management measures. Under the Classification, Labelling and Packaging regulation, notifications for substances of this profile assign acute toxicity in the highest categories by oral, dermal and inhalation routes, with the corresponding skull-and-crossbones pictogram, danger signal word and fatal-if-swallowed, fatal-in-contact-with-skin and fatal-if-inhaled statements, plus specific-target-organ effects. That classification determines packaging, labelling, handling controls and downstream obligations.
• Institutional Authorisation and End-Use Control: Beyond inventory law, European supply is governed by national implementation of rules on dangerous substances, on worker protection for carcinogenic, mutagenic and reprotoxic or highly toxic agents, and, where a member state treats the compound as a controlled or specially monitored research substance, by licensing and record-keeping duties. A responsible supplier requires a written end-use declaration naming the institution, investigator and protocol, and retains it.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA Inventory, Import Certification and Institutional Review: Import into the United States requires inventory compliance and the appropriate certification on entry, with correct hazard class and emergency-response documentation. Supply is additionally conditioned on institutional authorisation: approved animal-care-and-use and safety-committee review, documented training and a defined waste stream. Suppliers should refuse orders that cannot be matched to a named institution and a named responsible individual.
• Not a Drug, and Not Eligible for Drug Pathways: The substance has no approved therapeutic indication and is not a lawful subject of any clinical or compassionate-use pathway. It must not be described or promoted in terms suggesting any therapeutic utility, and enquiries implying human administration should be declined and documented. Requests framed around self-administration, performance or recreational effect are diversion indicators and must be refused outright.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Environmental, social and governance scrutiny of this material is distinct from that of ordinary fine chemicals, because the governing concern is containment and destruction rather than emissions intensity. Two questions dominate.

5.1 Containment Footprint and Destruction, Not Recycling

There is no circular-economy narrative for a potent neurotoxin, and a credible supplier will say so plainly. The environmental programme is built on containment and destruction: filtered exhaust, no discharge to effluent, collection of all rinse streams as hazardous waste, and destruction by licensed incineration with certificates retained. Energy use for cold storage and for negative-pressure containment is accepted as the cost of operating, and should be reported rather than optimised away.

5.2 Governance, Traceability and Duty of Care

Traceability is the ESG metric that matters here: a complete, auditable record from production through dispatch, receipt, use, and destruction, with named responsible individuals at each step and reconciliation of the quantity originally supplied against the quantity destroyed or returned. Duty of care extends to refusing onward transfer: material should not be resold, shared or transferred between institutions without repeating the full authorisation and declaration process.

VI. Supply Chain Resilience and Export Logistics

Logistics for this material are governed by toxic-substance transport rules and by the need to keep the container intact, cold and dark. Every decision is subordinated to preventing loss, breakage or diversion.

6.1 Packaging Standards and Moisture/Contamination Control

• Sealed Primary Container, Cold and Dark: Material should be supplied in a sealed primary container, typically amber glass with a fluoropolymer-lined closure, itself sealed inside a secondary containment vessel with absorbent, inside a rigid outer case, with tamper-evident sealing . Cold storage and light protection are required to limit oxidative degradation to the pyridinium species. Quantities should be kept to the minimum consistent with the approved protocol, since the amount shipped is the amount that must later be destroyed.
• Chain of Custody and Receipt Controls: Shipments should move on a secure, tracked service with signature by a named individual at a verified institutional address; post-office boxes, private residences and freight forwarders are refusal triggers. The recipient should log receipt, verify seal integrity and transfer the sealed container into the containment store.

6.2 Dangerous Goods Identification and Transit Protocols

On the classifications normally applied to a substance of this acute toxicity profile, consignment is as a toxic substance of Class 6.1, under the appropriate organic-toxic-solid entry such as UN2811, with the packing group set by the assigned acute-toxicity category and with packaging, marking, labelling and documentation to match. Routing must be confirmed before an order is accepted, since many carriers decline Class 6.1 consignments. Transit protocol is a secure courier, no consolidation, temperature and light protection, and pre-agreed return or destruction if delivery fails.

VII. Enterprise Global Expansion Strategy Guide

For any organisation considering whether to handle this substance at all, the strategy question is whether it can carry the governance burden. Three principles follow.

1. Qualify the Buyer Before Qualifying the Product: Build a documented know-your-customer and end-use-declaration process that verifies institutional status, investigator, approval reference and destination-country position. Screen explicitly for diversion indicators, including requests for bulk quantity, requests for synthetic information, and any language suggesting human use, and refuse those enquiries in writing.
2. Sell Certified Micro-Quantities with Full Metrology: Invest in the certificate rather than in the quantity: value assignment by quantitative nuclear magnetic resonance or mass balance, identity confirmation by liquid chromatography with mass spectrometry, individual limits for the pyridinium oxidation product, an expanded uncertainty statement, and homogeneity and stability data, produced under ISO/IEC 17025 and ISO 17034.
3. Own the End of the Life Cycle: Provide a documented destruction route, validate the inactivation method, retain destruction certificates and reconcile supplied against destroyed quantities. Customers and regulators judge a supplier of controlled research substances on the completeness of that file far more than on anything else the supplier does.

VIII. Conclusion

MPTP hydrochloride is not a chemical product in the ordinary commercial sense. It is a potent, irreversible dopaminergic neurotoxin with no approved therapeutic indication, supplied in minute quantities to licensed institutions for approved research and analytical purposes under institutional, national and international control. Its commerce is legitimate only when governance is: institutional authorisation, an end-use declaration, know-your-customer screening, import and export verification, high-band containment, medical surveillance and documented destruction.

The technical content of a defensible offering is correspondingly narrow: a certified micro-quantity, valued with a stated uncertainty, structurally confirmed, with the oxidation product individually limited, stored cold and sealed, and shipped as a Class 6.1 toxic substance. This paper provides no synthetic procedures, no precursor information, no process detail, no dosage and no human or animal use instructions, and such information should not be requested from any supplier. Any enquiry that seeks it is itself evidence that the enquiry should be refused.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global MPTP hydrochloride (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine HCl) Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global MPTP hydrochloride (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine HCl) supply chain:

• Europe — Accredited Reference-Material Producers: Established national-metrology-linked and commercial reference-material producers in Western Europe supply certified micro-quantities under ISO/IEC 17025 and ISO 17034, with full certificates. They operate within national controlled-substance frameworks and require institutional authorisation.
• North America — Specialist Research-Supply Channel: Suppliers serving universities, government laboratories and pharmaceutical safety functions provide research-grade and certified material under institutional review, with secure tracked courier delivery. Their distinguishing capability is the governance file: know-your-customer screening, protocol-reference capture and refusal of enquiries that fail screening.
• Asia — High-Containment Custom and Analytical Supply: A small number of Asian participants with high-containment capability supply regional research institutions and analytical laboratories under national controlled-substance rules and Class 6.1 documentation.